Economics at your fingertips  


Fiona Scott Morton

CPI Journal, 2013, vol. 9

Abstract: This article lays out the economics of competition between branded and generic pharmaceuticals and its welfare consequences. I explain the logic behind so-called “pay-for-delay†or “reverse payments†in the context of the current IP environment where weak (probabilistic) patents are frequently granted by the PTO. Fiona Scott Morton (Yale University).

Keywords: Fiona Scott Morton; pay-for-delay; reverse payments; competition; antitrust (search for similar items in EconPapers)
JEL-codes: K21 (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations: Track citations by RSS feed

Downloads: (external link) (application/pdf)
Requires login and subscription

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

More articles in CPI Journal from Competition Policy International
Bibliographic data for series maintained by Lindsay McSweeney ( this e-mail address is bad, please contact ).

Page updated 2021-12-01
Handle: RePEc:cpi:cpijrn:9.2.2013:i=13221